Shares of BioAge (NASDAQ:BIOA) cratered 70% Friday in post-market trading after the company said it was discontinuing a Phase ...
Regeneron Pharmaceuticals, Inc.'s stock faces challenges with Eylea's decline but potential growth from Dupixent. Click for ...
Intel Corporation's abrupt CEO removal prompts concerns about company direction and execution, leading to a sell downgrade.
Victoria's Secret & Co. reported its first positive comparable sales quarter in Q3 2024, with international sales driving an ...
We believe the short narrative that ULTA is structurally encroached is strongly misplaced, and we believe the pain has been ...
Hormel Foods Corporation faces growth challenges despite being a dividend king. Learn why HRL stock is downgraded and less ...
FitLife Brands focuses on sports supplements, a complex market highlighted by the lack of differentiation. Learn more about ...
Micron’s HBM3E ramp could lead to gross margin gains and capital returns. See why MU stock remains a top pick for investors ...
NewLake Capital Partners' undervalued stock offers strong yields and growth potential. See why NLCP stock is a solid choice ...
Investors breathed a sigh and poured into shares of Lululemon ( NASDAQ: LULU) as the company’s Q3 results showed enough ...
Supermicro's 143% rebound shows promise, but risks remain. Read why SMCI stock could be a risky but rewarding pick for those ...
Uber is undervalued, trading at 28 times '25 earnings. Check out why I think Uber shares could more than double by 2025 and ...